טוען...
Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis
BACKGROUND AND OBJECTIVES: The sodium glucose cotransporter 2 (SGLT-2) inhibitor dapagliflozin is a novel drug for the treatment of diabetes mellitus. Recent studies suggest that SGLT-2 inhibitors affect phosphate homeostasis, but their effects on phosphate-regulating hormones in patients with diabe...
שמור ב:
| הוצא לאור ב: | Clin J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Nephrology
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6364523/ https://ncbi.nlm.nih.gov/pubmed/30559106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.04530418 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|